Vinorelbine in Treating Children With Recurrent or Refractory Cancers
Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of vinorelbine in treating children with
recurrent or refractory cancer.